Suggestions

Du même auteur

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Archive ouverte | Bidard, François-Clément | CCSD

International audience

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Archive ouverte | Bidard, François-Clément | CCSD

International audience

Dépistage du cancer du sein : en route vers le futur

Archive ouverte | Delaloge, Suzette | CCSD

International audience. Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burde...

Chargement des enrichissements...